The strengths of etherna’s lipid based nanoparticle (LNP) platform have been showcased in a peer-reviewed paper in Advanced Functional Materials. etherna’s Vice President, Technology & Innovation, Stefaan De Koker described the paper as a “landmark” for the company and its technology. The RNA… Read More
mRNA technology discovery and development company, eTheRNA immunotherapies has announced it has relocated its R&D group to a larger site in Belgium. The company has moved its R&D facility to the Zwijnaarde Science Park in Gent, Belgium, which features a cluster of biotech companies and includes laboratories… Read More
Specialist RNA process developer eTheRNA Manufacturing has introduced a new Lipid Nanoparticle (LNP) formulation development and production service to support the discovery and early pre-clinical development of RNA-based therapeutics and vaccines. This new LNP service uses eTheRNA’s proprietary lipid libraries and formulations to facilitate targeted delivery and… Read More
Evonik met with a delegation of representatives from Canada at its site in Darmstadt to discuss competencies in lipid nanoparticles at Evonik’s Vancouver laboratories and evaluate future collaboration opportunities. Evonik has sites in seven locations in Canada including its Vancouver Laboratories in British Columbia for lipid-based parenteral… Read More
Listen to this article on the DDW Podcast: Lipids are essential for numerous functions in the human body. They are not only components of cell membranes, extracellular vesicles and hormones, but also store energy, facilitate metabolism, mediate cell signalling pathways, and much more. Afrisha Anderson, a Product Manager at… Read More
Scientific and technological advancements are making it easier to understand the causes of and physiological processes of diseases and how molecular and biochemical aspects of lipids play a role. Due to its promising application for identifying and quantifying lipids as biomarkers of disease, lipidomics research has advanced considerably in recent… Read More
Kim Ekroos PhD, Founder & CEO Lipidomics Consulting and Kelly Moser PhD, Lab Operations Manager and Applications Scientist, MOBILion Systems examine advancements in research of biomarkers for early diagnostics and effective treatments for neurodegenerative disorders with High-Resolution Ion Mobility Mass Spectrometry Although the first descriptions and classifications of lipids appeared… Read More
